Intrathecal baclofen for treatment of spasticity

Vanneste, J; Augustijn, P
August 1990
Journal of Neurology, Neurosurgery & Psychiatry;Aug1990, Vol. 53 Issue 8, p721
Academic Journal
case study
No abstract available.


Related Articles

  • The effects of intrathecally administered baclofen on function in patients with spasticity. Campbell, Suzann K.; Almeida, Gil L. // Physical Therapy;May1995, Vol. 75 Issue 5, p352 

    Reviews the documented effects of intrathecally administered baclofen on function in patients with spasticity. Framework for evaluation of the results of applying new treatments; Development of a protocol for studying the effects of intrathecally administered baclofen on functional outcomes in...

  • Manejo del síndrome de abstinencia por interrupción del baclofeno. Santana, Lisgelia; Quintero, Manuel // Colombian Journal of Anesthesiology / Revista Colombiana de Anes;May-Jul2012, Vol. 40 Issue 2, p158 

    Intrathecal baclofen therapy is a treatment that can relieve some symptoms of severe spasticity. Currently intrathecal baclofen infusion is used primarily for spasticity associated with cerebral palsy, brain or spinal injury, traumatic brain injury, anoxic encephalopathy, multiple sclerosis,...

  • Evolution of the Neurosurgical Management of Spasticity. Boop, Frederick A. // Journal of Child Neurology;Jan2001, Vol. 16 Issue 1, p54 

    Focuses on the evolution of neurological treatment options for managing spasticity. History of the neurological management of spasticity; Concept of selective dorsal rhizotomy; Advantage and disadvantage of intrathecal baclofen; Problems with spinal epidural electrical stimulation;...

  • Patient Information.  // Kids on Wheels;2009, p4 

    The article presents questions and answers related to baclofen injection including what severe spasticity is, the signs of rapid or abrupt withdrawal of intrathecal baclofen, and what to do to prevent baclofen underdose or abrupt discontinuation of intrathecal baclofen.

  • Baclofen/nabiximols.  // Reactions Weekly;7/20/2013, Issue 1462, p13 

    The article presents a case study of a woman with relapsing-remitting multiple sclerosis (MS) who developed sleepiness during treatment with intrathecal baclofen and dizziness during treatment with nabiximols for MS-related spasticity.

  • The safety of baclofen in pregnancy: intrathecal therapy in multiple sclerosis. Dalton, Catherine M.; Keenan, Elizabeth; Jarrett, Louise; Buckley, Lisa; Stevenson, Valerie L. // Multiple Sclerosis (13524585);May2008, Vol. 14 Issue 4, p571 

    Intrathecal baclofen is a GABA-receptor agonist and one of the mainstay treatments of severe spasticity due to multiple sclerosis (MS). The authors report a case on the use of intrathecal baclofen administered using a Medtronic Synchromed II infusion pump. A healthy male infant (2.68 kg, Apgars...

  • Deep Venous Thrombosis Associated With Use of Intrathecal Baclofen Pump in Chronic Spinal Cord Injury: A Report of Two Cases. SAFAZ, İsmail; KESIKBURUN, Serdar; TUĞCU, İlknur; ALACA, Rıdvan; TAN, Arif Kenan // Journal of Neurological Sciences;2014, Vol. 31 Issue 4, p842 

    By providing a direct and selective effect at the spinal cord level, intrathecal baclofen is used for the treatment of spasticity of spinal or cerebral origin, which is not alleviated with oral antispastic drugs. Besides its potent effect, it may result in several adverse events. The most common...

  • Baclofen withdrawal.  // Reactions Weekly;1/26/2008, Issue 1186, p13 

    The article describes the case of an 11-year-old girl who developed a severe drug withdrawal syndrome, following the discontinuation of intrathecal baclofen for treatment of spasticity associated with cerebral palsy. She had been treated continuously with baclofen via intrathecal pump since the...

  • Considerations in pharmacy compounding and the treatment of spasticity. Mullarkey, Tamira // American Journal of Health-System Pharmacy;9/2/2009, Vol. 66 Issue S5, pS2 

    The article discusses various reports published within the issue, including one on several considerations in pharmacy compounding, one on the treatment of spasticity, and the use of intrathecal baclofen (ITB) therapy.

  • Coma following intrathecal administration: case report.  // Reactions Weekly;8/27/2011, Issue 1366, p7 

    The article describes the case of a 41-year-old woman with spastic paraplegia who presented with increased muscle spasm after a year of treatment with intrathecal baclofen and became comatose when a physician increased her dose twice.


Read the Article


Sign out of this library

Other Topics